Literature DB >> 26382308

Preoperative biliary drainage in perihilar cholangiocarcinoma: identifying patients who require percutaneous drainage after failed endoscopic drainage.

Jimme K Wiggers1, Bas Groot Koerkamp2, Robert J Coelen1, Erik A Rauws3, Mark A Schattner4, C Yung Nio5, Karen T Brown6, Mithat Gonen7, Susan van Dieren8, Krijn P van Lienden5, Peter J Allen2, Marc G H Besselink1, Olivier R C Busch1, Michael I D'Angelica2, Robert P DeMatteo2, Dirk J Gouma1, T Peter Kingham2, William R Jarnagin2, Thomas M van Gulik1.   

Abstract

BACKGROUND AND STUDY AIMS: Preoperative biliary drainage is often initiated with endoscopic retrograde cholangiopancreatography (ERCP) in patients with potentially resectable perihilar cholangiocarcinoma (PHC), but additional percutaneous transhepatic catheter (PTC) drainage is frequently required. This study aimed to develop and validate a prediction model to identify patients with a high risk of inadequate ERCP drainage. PATIENTS AND METHODS: Patients with potentially resectable PHC and (attempted) preoperative ERCP drainage were included from two specialty center cohorts between 2001 and 2013. Indications for additional PTC drainage were failure to place an endoscopic stent, failure to relieve jaundice, cholangitis, or insufficient drainage of the future liver remnant. A prediction model was derived from the European cohort and externally validated in the USA cohort.
RESULTS: Of the 288 patients, 108 (38%) required additional preoperative PTC drainage after inadequate ERCP drainage. Independent risk factors for additional PTC drainage were proximal biliary obstruction on preoperative imaging (Bismuth 3 or 4) and predrainage total bilirubin level. The prediction model identified three subgroups: patients with low risk (7%), moderate risk (40%), and high risk (62%). The high-risk group consisted of patients with a total bilirubin level above 150 µmol/L and Bismuth 3a or 4 tumors, who typically require preoperative drainage of the angulated left bile ducts. The prediction model had good discrimination (area under the curve 0.74) and adequate calibration in the external validation cohort.
CONCLUSIONS: Selected patients with potentially resectable PHC have a high risk (62%) of inadequate preoperative ERCP drainage requiring additional PTC drainage. These patients might do better with initial PTC drainage instead of ERCP. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2015        PMID: 26382308      PMCID: PMC4745253          DOI: 10.1055/s-0034-1392559

Source DB:  PubMed          Journal:  Endoscopy        ISSN: 0013-726X            Impact factor:   10.093


  30 in total

1.  Development and validation of a prediction model with missing predictor data: a practical approach.

Authors:  Yvonne Vergouwe; Patrick Royston; Karel G M Moons; Douglas G Altman
Journal:  J Clin Epidemiol       Date:  2009-07-12       Impact factor: 6.437

2.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

3.  Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer.

Authors:  Juan Valle; Harpreet Wasan; Daniel H Palmer; David Cunningham; Alan Anthoney; Anthony Maraveyas; Srinivasan Madhusudan; Tim Iveson; Sharon Hughes; Stephen P Pereira; Michael Roughton; John Bridgewater
Journal:  N Engl J Med       Date:  2010-04-08       Impact factor: 91.245

4.  Oncological superiority of hilar en bloc resection for the treatment of hilar cholangiocarcinoma.

Authors:  Peter Neuhaus; Armin Thelen; Sven Jonas; Gero Puhl; Timm Denecke; Wilfried Veltzke-Schlieker; Daniel Seehofer
Journal:  Ann Surg Oncol       Date:  2011-10-01       Impact factor: 5.344

5.  Preoperative endoscopic nasobiliary drainage in 164 consecutive patients with suspected perihilar cholangiocarcinoma: a retrospective study of efficacy and risk factors related to complications.

Authors:  Hiroki Kawashima; Akihiro Itoh; Eizaburo Ohno; Yuya Itoh; Tomoki Ebata; Masato Nagino; Hidemi Goto; Yoshiki Hirooka
Journal:  Ann Surg       Date:  2013-01       Impact factor: 12.969

6.  Multidisciplinary management of hilar cholangiocarcinoma (Klatskin tumor): extended resection is associated with improved survival.

Authors:  T M van Gulik; J J Kloek; A T Ruys; O R C Busch; G J van Tienhoven; J S Lameris; E A J Rauws; D J Gouma
Journal:  Eur J Surg Oncol       Date:  2010-11-27       Impact factor: 4.424

7.  Role of preoperative biliary drainage of liver remnant prior to extended liver resection for hilar cholangiocarcinoma.

Authors:  Timothy J Kennedy; Adam Yopp; Yilin Qin; Binsheng Zhao; Pingzhen Guo; Fan Liu; Larry H Schwartz; Peter Allen; Michael D'Angelica; Yuman Fong; Ronald P DeMatteo; Leslie H Blumgart; William R Jarnagin
Journal:  HPB (Oxford)       Date:  2009-08       Impact factor: 3.647

8.  Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver.

Authors:  H Bismuth; M B Corlette
Journal:  Surg Gynecol Obstet       Date:  1975-02

9.  Preoperative cholangitis independently increases in-hospital mortality after combined major hepatic and bile duct resection for hilar cholangiocarcinoma.

Authors:  Jun Sakata; Yoshio Shirai; Yoshiaki Tsuchiya; Toshifumi Wakai; Tatsuya Nomura; Katsuyoshi Hatakeyama
Journal:  Langenbecks Arch Surg       Date:  2009-01-24       Impact factor: 3.445

10.  Proposal to modify the International Union Against Cancer staging system for perihilar cholangiocarcinomas.

Authors:  T Ebata; T Kosuge; S Hirano; M Unno; M Yamamoto; M Miyazaki; N Kokudo; S Miyagawa; T Takada; M Nagino
Journal:  Br J Surg       Date:  2014-01       Impact factor: 6.939

View more
  16 in total

1.  Comparing the efficacy of initial percutaneous transhepatic biliary drainage and endoscopic retrograde cholangiopancreatography with stenting for relief of biliary obstruction in unresectable cholangiocarcinoma.

Authors:  S O'Brien; N Bhutiani; M E Egger; A N Brown; K H Weaver; D Kline; L R Kelly; C R Scoggins; R C G Martin; G C Vitale
Journal:  Surg Endosc       Date:  2019-05-28       Impact factor: 4.584

2.  Compliance with evidence-based multidisciplinary guidelines on perihilar cholangiocarcinoma.

Authors:  Robert Js Coelen; Joost Huiskens; Pim B Olthof; Eva Roos; Jimme K Wiggers; Annuska Schoorlemmer; Otto M van Delden; Heinz-Josef Klümpen; Erik Aj Rauws; Thomas M van Gulik
Journal:  United European Gastroenterol J       Date:  2016-09-30       Impact factor: 4.623

3.  External biliary drainage following major liver resection for perihilar cholangiocarcinoma: impact on development of liver failure and biliary leakage.

Authors:  Pim B Olthof; Robert J S Coelen; Jimme K Wiggers; Marc G H Besselink; Olivier R C Busch; Thomas M van Gulik
Journal:  HPB (Oxford)       Date:  2016-02-18       Impact factor: 3.647

4.  Palliative endoscopic drainage of malignant stenosis of biliary confluence: Efficiency of multiple drainage approach to drain a maximum of liver segments.

Authors:  Fabrice Caillol; Erwan Bories; Christophe Zemmour; Christian Pesenti; Jean Philippe Ratone; Marine Gilabert; Simon Launay; Marc Giovannini
Journal:  United European Gastroenterol J       Date:  2018-09-27       Impact factor: 4.623

5.  An Unsuccessful Randomized Trial of Percutaneous vs Endoscopic Drainage of Suspected Malignant Hilar Obstruction.

Authors:  B Joseph Elmunzer; Zachary L Smith; Paul Tarnasky; Andrew Y Wang; Patrick Yachimski; Filip Banovac; Jonathan M Buscaglia; James Buxbaum; Amitabh Chak; Bradford Chong; Gregory A Coté; Peter V Draganov; Kulwinder Dua; Valerie Durkalski; Brian S Geller; Laith H Jamil; Rajesh N Keswani; Mouen A Khashab; Ryan Law; Simon K Lo; Sean McCarthy; J Bayne Selby; Vikesh K Singh; Jason R Taylor; Field F Willingham; Rebecca L Spitzer; Lydia D Foster
Journal:  Clin Gastroenterol Hepatol       Date:  2020-05-23       Impact factor: 11.382

Review 6.  Malignant Biliary Obstruction: Evidence for Best Practice.

Authors:  Leonardo Zorrón Cheng Tao Pu; Rajvinder Singh; Cheong Kuan Loong; Eduardo Guimarães Hourneaux de Moura
Journal:  Gastroenterol Res Pract       Date:  2016-02-11       Impact factor: 2.260

7.  Percutaneous transhepatic vs. endoscopic retrograde biliary drainage for suspected malignant hilar obstruction: study protocol for a randomized controlled trial.

Authors:  Firas Al-Kawas; Harry Aslanian; John Baillie; Filip Banovac; Jonathan M Buscaglia; James Buxbaum; Amitabh Chak; Bradford Chong; Gregory A Coté; Peter V Draganov; Kulwinder Dua; Valerie Durkalski; B Joseph Elmunzer; Lydia D Foster; Timothy B Gardner; Brian S Geller; Priya Jamidar; Laith H Jamil; Rajesh N Keswani; Mouen A Khashab; Gabriel D Lang; Ryan Law; David Lichtenstein; Simon K Lo; Sean McCarthy; Silvio Melo; Daniel Mullady; Jose Nieto; J Bayne Selby; Vikesh K Singh; Rebecca L Spitzer; Brian Strife; Paul Tarnaksy; Jason R Taylor; Jeffrey Tokar; Andrew Y Wang; April Williams; Field Willingham; Patrick Yachimski
Journal:  Trials       Date:  2018-02-14       Impact factor: 2.279

Review 8.  Modern work-up and extended resection in perihilar cholangiocarcinoma: the AMC experience.

Authors:  F Rassam; E Roos; K P van Lienden; J E van Hooft; H J Klümpen; G van Tienhoven; R J Bennink; M R Engelbrecht; A Schoorlemmer; U H W Beuers; J Verheij; M G Besselink; O R Busch; T M van Gulik
Journal:  Langenbecks Arch Surg       Date:  2018-01-19       Impact factor: 3.445

9.  Ablation with irreversible electroporation in patients with advanced perihilar cholangiocarcinoma (ALPACA): a multicentre phase I/II feasibility study protocol.

Authors:  Robert J S Coelen; Jantien A Vogel; Laurien G P H Vroomen; Eva Roos; Olivier R C Busch; Otto M van Delden; Foke van Delft; Michal Heger; Jeanin E van Hooft; Geert Kazemier; Heinz-Josef Klümpen; Krijn P van Lienden; Erik A J Rauws; Hester J Scheffer; Henk M Verheul; Jan de Vries; Johanna W Wilmink; Barbara M Zonderhuis; Marc G Besselink; Thomas M van Gulik; Martijn R Meijerink
Journal:  BMJ Open       Date:  2017-09-01       Impact factor: 2.692

10.  A Retrospective Study of Biliary Drainage Strategies for Patients with Malignant Hilar Biliary Strictures.

Authors:  Xin-Yue Liang; Wen Li; Fang Liu; Xin-Dan Kang
Journal:  Cancer Manag Res       Date:  2021-06-17       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.